1027984-52-6

Upstream product

• 1321914-20-8 (2,4,5-trimethoxyphenylethynyl)trimethylsilane 
• 135-77-3 1,2,4-trimethoxy-benzene 
• 20129-11-7 1-bromo-2,4,5-trimethoxybenzene 
• 1321914-12-8 N-{7-benzyl-4-methyl-5-[(2,4,5-trimethoxyphenyl)ethyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}-N-(2,2-dimethylpropanoyl)-2,2-dimethylpropanamide 
• 1321914-01-5 N-{7-benzyl-4-methyl-5-[(2,4,5-trimethoxyphenyl)ethynyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}-N-(2,2-dimethylpropanoyl)-2,2-dimethylpropanamide 
• 101911-62-0 2,4,5-trimethoxyphenylacetylene 

Relevant academic research and scientific papers

2-Amino-4-methyl-5-phenylethyl substituted-7-N-benzyl-pyrrolo[2,3-d] pyrimidines as novel antitumor antimitotic agents that also reverse tumor resistance

Gangjee et al. recently reported a novel series of 2-amino-4-methyl-5- phenylethyl substituted-7-benzyl-pyrrolo[2,3-d]pyrimidines, some of which exhibited two digit nanomolar antitumor and antimitotic activity and were not subject to P-glycoprotein (Pgp)